The North America Vendor Neutral Archive (VNA) & PACS Market would witness market growth of 8.6% CAGR during the forecast period (2024-2031).
The US market dominated the North America Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,228 million by 2031. The Canada market is experiencing a CAGR of 10.7% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10% during (2024 - 2031).
Vendor neutral archive (VNA) and picture archiving and communication system (PACS) systems facilitate seamless imaging data sharing across different healthcare facility departments. This capability allows for integrated care where specialists from radiology, oncology, cardiology, and other departments can collaborate efficiently using a unified imaging data set. It promotes coordinated patient care by ensuring all healthcare providers can access the most current and comprehensive imaging information.
VNA systems support the creation of longitudinal imaging records, which track a patient's imaging history over time. This feature is particularly valuable for managing chronic conditions and long-term treatments, as it provides a comprehensive view of disease progression or treatment response. It helps monitor changes, assess the effectiveness of interventions, and make informed decisions based on historical imaging data.
As cancer cases rise in Mexico, there will be a greater need for diagnostic imaging services. This increase in demand will drive the adoption of advanced PACS and VNA systems to manage, store, and access high volumes of imaging data efficiently. As per the All. Can, cancer is the third leading cause of death in Mexico. Over 195,000 new cases were registered in 2020. Breast (29.929), prostate (26.742), thyroid (11,227), colon (11,191), and cervical cancer (9,439) were among those with the highest prevalence. With the rise in CVD cases, imaging procedures such as echocardiograms, CT scans, and MRIs will be used more frequently to diagnose and manage these conditions. This will drive demand for VNA and PACS systems capable of efficiently handling large volumes of imaging data. According to the American Heart Association, cardiovascular disease (CVD) remains the leading cause of death in the United States, accounting for 928,741 deaths in 2020. In conclusion, high rates of cancer cases and the increasing burden of CVDs in the region are driving the growth of the market.
Free Valuable Insights: The Vendor Neutral Archive (VNA) & PACS Market is Predict to reach USD 8.3 Billion by 2031, at a CAGR of 9.3%
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on Application, the market is segmented into Cardiology, Orthopedic, Oncology, Neurology, Obstetrics & Gynecology, and Others. Based on Modality, the market is segmented into Computed Tomography, Mammography, MRI, Ultrasound, X-Rays, and PET. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By Product Type
By Vendor Type
By Deployment
By End User
By Application
By Modality
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 